Business   

Avesthagen gets Australian patent

BANGALORE: Avestha Gengraine Technologies Pvt. Ltd. (Avesthagen), the Bangalore-based biotechnology company, has received a patent from the Australian Patent Office for ‘a process for generating cytoplasmic male sterile line in rice and other crops by RNA (cybonucleic acid) editing’.

This promises opportunities to develop hybrids in crops where conventional male sterility is not available or feasible, a release from the company says.

This technology will allow hybrid seed programmes to be developed without narrowing the diversity of germplasm. It opens up more crops for hybrid seed production and it can be transferred to any other crop, within a short time span, as the technology is not crop specific.

This patent closely follows the previous patent approval received by Avesthagen in South Africa and Australia for genetically modified millets, according to Vice-Chairman and Managing Director Vinoo Morawala Patel. Over the years, Avesthagen has built a portfolio of 137 patent applications, 61 of them related to the agri-biotech domain, she added.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

RIL gas pricing formula approved
Rangarajan wants capital base of PSBs enlarged
Industrial growth slumps to 7.1 p.c. in July
RIL, REL hog limelight
Avesthagen gets Australian patent
Sahara launches new products
Host your own website from any PC
Bulgaria for closer economic ties
Fresh rise in rupee
Exchange Rates
Bullion Rates
BSE, ICSI sign MoU
CFO Strategies India forum meet
Siemens buys balance stake in SITS
DLF replaces IPCL in BSE-100 index
Wipro Infotech launches supercomputers
Tally’s programme for students
Quscient gets recognition
City Union Bank interconnects branches
ASK Group expands presence in South
Huclin Research bags Rs. 16-cr. contract
Airtel’s new Chairman for Sri Lanka

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu